A practical reference on albumin conjugate: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-23. Anything still debated is marked as such rather than presented as settled.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | Reverse-phase HPLC | Reported as area percentage |
| Identity confirmation | Mass spectrometry | Electrospray or laser desorption |
| Powder storage | Minus 20 degrees Celsius or lower | Dark and dry conditions |
| Solution storage | Two to eight degrees Celsius | Avoid repeated freeze-thaw |
| Appearance | White to off-white powder | Common lyophilized form |
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
== Honors and awards == EAS Award for Outstanding Achievements in the Fields of Analytical Chemistry (2023) Martin Medal (2019) Ralph N. Adams Award in Bioanalyical Chemistry (2016) ACS Award in Chromatography (2017) CASSS Award for Outstanding Achievements in Separation Science (2017) Marcel Golay Award for Lifetime Achievement in Capillary Chromatography (2012) Eastern Analytical Symposium Award for Separation Science (2012) McKnight Award for Technical Innovations in Neuroscience (2010) Rackham Distinguished Faculty Achievement Award (2009) American Microchemical Society's Benedetti-Pichler Memorial Award (2001)
Candelariella deppeanae is a species of lichen in the family Candelariaceae. Found in southwestern North America, it was formally described as a new species in 2007 by the Swedish lichenologist Martin Westberg. The type specimen was collected in the Chiricahua Mountains (Chiricahua National Monument, Arizona) at an elevation of 1,750 m (5,740 ft). Here, in an oak forest, it was found growing on a decorticated (barkless) part of alligator juniper (Juniperus deppeana). Most collections of the lichen are from the wood or trunks of this juniper plant; the species epithet deppeanae alludes to this close relationship. The lichen has a greenish-yellow to yellow, granular to areolate thallus. It has also been collected in Texas, and from Chihuahua, Baja California Norte and Baja California Sur. The lichen grows mainly on wood and decorticated trunks, but has also been less frequently recorded growing on bark. Secondary chemicals that have been detected in Candelariella deppeanae (using high-performance liquid chromatography) include calycin, pulvic acid lactone, vulpinic acid, and pulvinic acid.
Myofibrillar myopathy 10, dimethylglycine dehydrogenase deficiency, erythrocyte lactate transporter defect, and myopathy with myalgia, increased serum creatine kinase, with or without episodic rhabdomyolysis (MMCKR) also include muscle fatigue. X-linked episodic muscle weakness (EMWX) includes general muscle weakness, ptosis, and fluctuations in strength. In some individuals, fatiguability was demonstrable, the phenotype having features comparable to congenital myasthenic syndromes and channelopathies. Signs and symptoms of myasthenia presenting from infancy or childhood may be one of the congenital myasthenic syndromes, which can be inherited in either an autosomal dominant or recessive manner. There are currently over two dozen types of congenital myasthenic syndromes. Limb–girdle myasthenia gravis is a distinct condition from myasthenia gravis. It is an adult-onset, autoimmune condition affecting the neuromuscular junction. However, it lacks eye abnormalities and is associated with autoimmune conditions such as systemic lupus erythematosus, Hashimoto's thyroiditis, and thymoma. Lambert–Eaton myasthenic syndrome (LEMS) is an autoimmune condition that attacks the neuromuscular junction, either as a paraneoplastic syndrome (typically older people) or associated with a non-cancerous primary autoimmune condition (typically younger people). It usually involves lower limb weakness and exercise-induced fatiguability, although the upper limbs and eyes may also be involved.
1993/335) Southport and Formby National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/336) Bassetlaw Hospital and Community Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/337) Dorset Healthcare National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/338) Southmead Health Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/339) Central Region (Electoral Arrangements) Order 1993 (S.I. 1993/340) Local Government Finance (Scotland) Order 1993 (S.I. 1993/341) Council Tax (Discounts) (Scotland) Amendment Regulations 1993 (S.I. 1993/342) Council Tax (Discounts) (Scotland) Amendment Order 1993 (S.I. 1993/343) Council Tax (Liability of Owners) (Scotland) Amendment Regulations 1993 (S.I. 1993/344) Council Tax (Exempt Dwellings) (Scotland) Amendment Order 1993 (S.I. 1993/345) Consumer Credit (Exempt Agreements) (Amendment) Order 1993 (S.I. 1993/346) Training for Work (Miscellaneous Provisions) Order 1993 (S.I. 1993/348) Social Security Benefits Up-rating Order 1993 (S.I. 1993/349) Statutory Sick Pay (Rate of Payment) Order 1993 (S.I. 1993/350) Poole Hospital National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/351) St George's Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/352) Chester and Halton Community National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/353) Council Tax (Valuation of Dwellings) (Scotland) Amendment Regulations 1993 (S.I.
Sources: en.wikipedia.org
Legal experts such as Janina Dill (co-director of the Oxford Institute for Ethics, Law and Armed Conflict) have weighed in on Trump's rationale, saying that the argument that it would benefit the people living in a territory is no justification (legal or otherwise) for seizing it by force. The Brookings Institute's Natan Sachs reiterates this point and adds that the proposal would be incredibly difficult and expensive to pull off, as well as risking "the implementation of the second phase of the ceasefire-hostage deal." In Haaretz, Dahlia Scheindlin described the alleged plans as "bereft of logic or fact", and analysed the ways in which the far-right in Israel (and elsewhere) had seized on the plan, criticizing the "fuzzy, fake math" being used to suggest that Palestinians would support Trump's move. CNN's Stephen Collinson wrote that the plan would also be unpopular at home in the US, given that, in his words, Trump "partly owes his rise to a political base wearied by sending its sons and daughters to war in the post-9/11 era." fr:Dominique Vidal, a French expert on the Middle East, compared this proposal to the Madagascar Plan, a prelude to the Final Solution. Al Jazeera said that Trump does not have the ability to carry out his plan whether legally, militarily, or diplomatically. Reuters said that it was not clear if Trump would move forward with the plan or if the proposal was an extreme negotiation tactic. Critics have said his first term was full of exaggerated foreign policy announcements, of which many were never implemented.
=== Public awareness === Public awareness of the disease, which is spread through the exchange of bodily fluids, is not as high as it is for HIV and AIDS. In some rural areas, doctors have reused syringes and unknowingly spread the disease, particularly among children.
== Pharmacology: Pharmacodynamics/Mechanism of Action(MOA) == Synthetic cannabinoids act as Synthetic Cannabinoid Receptor Agonists (SCRA) by binding to cannabinoid receptors CB1 and CB2 . Its binding towards CB1 receptor will lead to receptor phosphorylation that recruits β-arrestin 1 and β-arrestin 2, resulting in a loss of responsiveness and internalization (endocytosis of molecules by the cell). Stimulation of CB1 receptor causes the dissociation of the βγ subunits of pertussis toxin-sensitive G proteins (Gi /Go) from the α subunit (Giα) which then contributes to acute inhibition of synaptic neurotransmitter release. β-arrestin can also stimulate the mitogen-activated protein kinase, thus inducing additional cellular effects. Synthetic cannabinoids can also bind to receptors other than CB1 and CB2 to activate inotropic transient receptor potential channels for cell membrane depolarization and Ca2+ influx.
Sources: en.wikipedia.org
== Carbamino compounds in blood == The concentration of carbamate (HbCO2) was estimated in oxygenated and deoxygenated red blood cells of adult and fetal humans. The estimation was carried out at a constant pressure of carbon dioxide (PCO2 = 40 mm Hg) and varied pH levels of the serum. The bicarbonate concentration in the red cells was calculated using the Donnan ratio for chloride and bicarbonate ions. Based on this figure, the carbamate concentration was determined by subtracting the bicarbonate concentration and dissolved CO2 from the total CO2 concentration. Deoxygenated fetal red cells contain more HbCO2 than deoxygenated adult red cells at a given pH value in the red cell. Upon oxygenation, HbCO2 decreased in both types of erythrocytes to values lower than in deoxygenated cells, at a constant pH. The fraction of 'oxylabile carbamate' (-ΔHbCO2/ΔHbO2) at a red cell pH of 7·2 and a PCO2 of 40 mm Hg is 0·117 in fetal and 0·081 in adult erythrocytes. The apparent carbamate equilibrium constants (K'c and K'z) were calculated from the fraction of moles carbamate formed per Hb monomer (moles CO2/mole Hbi). These constants can be used to estimate the carbamate concentration in normal adult and fetal blood. In adult red cells, the first apparent dissociation constant of carbonic acid is significantly higher in oxygenated (-log10K'1 = pK'1 = 6·10) than in deoxygenated (pK'1 = 6·12) red cells, whereas in fetal red cells, the difference is smaller and statistically not significant.
Harm reduction covers measures that reduce the damage associated with continued substance use. Approaches include needle and syringe programs, naloxone distribution to reverse opioid overdose, drug checking, and supervised consumption facilities. Opioid agonist maintenance treatment also functions as harm reduction: independently of whether use stops, it is associated with reduced mortality and with a lower risk of acquiring hepatitis C. A 2023 systematic review of global coverage reported that provision of these services remains limited, with only nine countries implementing all five.
=== Definition === The EU defines biopesticides as "a form of pesticide based on micro-organisms or natural products". The US EPA defines biopesticides as “certain types of pesticides derived from such natural materials as animals, plants, bacteria, and certain minerals”. Microorganisms that control pests may also be categorised as biological pest control agents together with larger organisms such as parasitic insects, entomopathic nematodes etc. Natural products may also be categorised as chemical insecticides. The US EPA describes three types of biopesticide. Biochemical pesticides (meaning bio-derived chemicals), which are naturally occurring substances that control pests by non-toxic mechanisms. Microbial pesticides consisting of a microorganism (e.g., a bacterium, fungus, virus or protozoan) as the active ingredient. Plant-Incorporated-Protectants (PIPs) are pesticidal substances that plants produce from genetic material that has been added to the plant (thus producing transgenic crops).
The UK quits the Energy Charter Treaty, which had allowed fossil fuel companies to sue governments over profits lost in the drive towards net zero. Data from the Office for National Statistics shows a surplus in government finances of £16.7bn in January 2024, more than double the figure for January 2023. 22 February More than 60 MPs have signed a House of Commons motion calling for the resignation of Speaker Sir Lindsay Hoyle. A further 50 sanctions against Russia are announced, aimed at restricting those supplying its military with munitions such as rocket launchers, missiles and explosives. Employees of a company contracted by the Home Office are suspended after a baby's birth certificate was returned to the parents with the place of birth, Israel, crossed out. The UK government announces that legislation will be introduced to clear hundreds of sub-postmasters in England and Wales who were wrongly convicted as a result of the Horizon IT scandal. 23 February Thousands of people in the Keyham area of Plymouth, Devon are evacuated as an unexploded World War II bomb is moved by military convoy for disposal at sea. The bomb was discovered in a garden three days prior. This is also the first time that the UK Emergency Alert System is used in a live situation. Ofgem confirms that the average annual energy bill will fall by £238 from April to £1,690, its lowest rate for two years. Shamima Begum loses her legal bid to overturn the decision to revoke her UK citizenship. Ibrahima Bah is sentenced to nine years and six months in prison.
Sources: en.wikipedia.org
The powder is normally held at minus twenty degrees Celsius or below. Light and moisture exposure should be minimized. Repeated warming and cooling cycles are avoided.
Reverse-phase high-performance liquid chromatography is used for purity. Mass spectrometry confirms molecular weight and sequence integrity. Amino acid analysis offers an additional compositional check.
Published stability data for dissolved material are limited and vary with conditions. Refrigerated solutions are generally used within a short period. The exact shelf life depends on concentration, buffer, and handling.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.